Look for our NEW booth!
presented by
Dr. Baljit Singh
Chief Executive Officer
INOVIS AG
(formerly Director Insights, Novartis Pharma AG)
![]()
In a rapidly evolving pharmaceutical landscape shaped by AI, regulatory shifts, and commercialization pressures and VUCA (Volatility, Uncertainty, Complexity, and Ambiguity), the objective of this keynote is to spotlight the strategic edge offered by Primary Competitive Intelligence (CI). This session explores how primary CI—grounded in direct, real-world insight—can inform timely course correction, future-proof decision-making, and sharpen competitive advantage across the product lifecycle from early stage evaluation to late life cycle management.
What's in it for you? Attendees will gain practical understanding of how to integrate primary CI into strategic execution and how deeper insights and how a four-pronged methodology translates to measurable impact leading to strategic advantage.
